Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01241656 · ClinicalTrials.gov registry record · NA
Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1
A NA study of Healthy Men Age 50 Who Are Considering PSA Screening, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 2,521
- Enrollment target
- 2
- Study locations
NCT01241656: Completed NA study of Healthy Men Age 50 Who Are Considering PSA Screening, sponsored by University of North Carolina, Chapel Hill.
NCT01241656 is a NA study of Healthy Men Age 50 Who Are Considering PSA Screening that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 2,521 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01241656, a NA study of Healthy Men Age 50 Who Are Considering PSA Screening, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,521 participants
- Enrollment target
- 2
- Study locations
Study Summary
In this study we will compare 3 strategies for systematic delivery of prostate cancer screening decision support interventions (DESI) to usual care and examine their impact on screening decisions and subsequent healthcare utilization using a randomized control design. We hypothesize men who are given the opportunity to review a DESI by one of the 3 strategies will be less likely to opt for prostate cancer screening, and will have lower subsequent healthcare utilization than men in the control group.
Primary Outcome
We will determine whether a DESI viewing had an impact on testing.
Conditions Studied
Interventions
- BEHAVIORAL DESI for home viewing
- BEHAVIORAL DESI for viewing at Shared Medical Appointment
- BEHAVIORAL Option of SMA and DESI or DESI only
Study Locations (2)
California
- Palo Alto Medical Foundation Research Institute - Palo Alto
North Carolina
- University of North Carolina, Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,521 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-12 |
| Phase | NA |
What the finished NCT01241656 record still lists
NCT01241656 is an interventional study that assigns participants to a tested intervention. Its 2,521 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% higher).
The record links to 1 condition, with Healthy Men Age 50 Who Are Considering PSA Screening appearing as the primary indexed condition, and to 3 interventions - of which DESI for home viewing is the first listed.
NCT01241656 reports a single indexed study location in California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01241656 about?
NCT01241656 is a clinical study titled "Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1". In this study we will compare 3 strategies for systematic delivery of prostate cancer screening decision support interventions (DESI) to usual care and examine their impact on screening decisions and subsequent healthcare utilization using a randomized control design. We hypothesize men who are giv...
What is the current status of trial NCT01241656?
This trial is currently completed. It is a NA study. The enrollment target is 2,521 participants. The study started on 2011-01. Estimated completion is 2012-12.
What conditions does trial NCT01241656 study?
This clinical trial studies the following conditions: Healthy Men Age 50 Who Are Considering PSA Screening.
What interventions are being tested in trial NCT01241656?
The interventions under investigation include: DESI for home viewing (BEHAVIORAL), DESI for viewing at Shared Medical Appointment (BEHAVIORAL), Option of SMA and DESI or DESI only (BEHAVIORAL).
Who is sponsoring clinical trial NCT01241656?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01241656 being conducted?
This trial has 2 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01241656's enrollment target sits among peer trials
2,521 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04142177 · 2,529 participants · NA
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
- NCT00018057 · 2,530 participants · Phase 2
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- NCT05931276 · 2,540 participants · Phase 3
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia